Micro-Implant
drug delivery

Proof of concept studies successfully carried out

Ocelus Ltd, in conjunction with an independent skin testing laboratory, confirmed that proof of concept studies have successfully demonstrated the ability of the Ocelus technology to deliver microparticles into the epidermis. Further work is currently underway to refine the technology.